JENNIFER GIBSON: Open Payments
NPI 1194002162 · IRONTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 51 payments from 9 companies in 2025. Trend: 2023 $684 · 2024 $617 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| ABBVIE INC. | 17 | $202 |
| Novo Nordisk Inc | 10 | $169 |
| PFIZER INC. | 6 | $88 |
| Lilly USA, LLC | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
Products named: Wegovy, VRAYLAR, FARXIGA, AIRSUPRA, ELIQUIS, QULIPTA, JARDIANCE, MOUNJARO.
Industry payments across OH — which companies pay providers there.
